Rx&D Welcomes its Newest Member: Bristol-Myers Squibb Canada

OTTAWA, May 31, 2011 /CNW/ - Canada's Research-Based Pharmaceutical Companies (Rx&D) President Russell Williams is pleased to welcome a new member to the association representing the innovative pharmaceutical industry in Canada.

Bristol-Myers Squibb Canada is a subsidiary of Bristol-Myers Squibb Company, a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. Bristol-Myers Squibb Canada is a leading provider of medicines to fight cancer, cardiovascular and metabolic disorders, infectious diseases (including HIV/AIDS), nervous system diseases and serious mental illness. Bristol-Myers Squibb Company is listed on the New York Stock Exchange under the BMY symbol (NYSE: BMY). Bristol-Myers Squibb Canada's operations are headquartered in Montréal, Québec.

"As Bristol-Myers Squibb grows by bringing our strong portfolio of innovative medicines to Canadians, we feel it is important for us to play a more active role in the broader industry," said Teresa Bitetti, President and General Manager of Bristol-Myers Squibb Canada. "Being a member of Rx&D allows us to do that and we look forward to doing so."

"More and more companies are recognizing the value and benefits of becoming members of Rx&D. We are pleased to welcome Bristol-Myers Squibb Canada into our association as they bring their distinctive expertise which gives us a broader foundation, making the research-based pharmaceutical industry stronger," said Rx&D President Russell Williams.

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.


For further information:

Christine Choury, Media Relations
Telephone: 613.236.0455
E-mail: cchoury@canadapharma.org

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890